Skip to main content

Table 4 Organ absorbed doses (mGy/MBq) and ED values (mSv/MBq) per unit administered activity calculated for xxxTb-cm09 for male ICRP 89 phantoms

From: 155Tb production by cyclotrons: what level of 155Gd enrichment allows clinical applications?

Target organ

154gTb-cm09

155Tb-cm09

156gTb-cm09

156m1Tb-cm09

156m2Tb-cm09

Adreanals

1.68E-01

6.56E-02

4.69E-01

6.78E-03

1.44E-03

Brain

2.61E-02

9.25E-03

5.68E-02

1.38E-03

1.22E-03

Esophagus

4.93E-02

1.52E-02

1.10E-01

1.98E-03

1.24E-03

Eyes

2.58E-02

9.09E-3

5.57E-02

1.36E-03

1.22E-03

Gallbladder wall

7.75E-02

2.66E-02

1.97E-01

3.05E-03

1.27E-03

Left colon

5.91E-02

2.04E-02

1.44E-01

2.50E-03

1.71E-03

Small intestine

5.10E-02

1.67E-02

1.19E-01

2.11E-03

1.71E-03

Stomach wall

5.60E-02

1.87E-02

1.29E-01

2.49E-03

2.05E-03

Right colon

5.59E-02

1.87E-02

1.34E-01

2.31E-03

1.71E-03

Rectum

4.13E-02

1.33E-02

9.11E-02

1.80E-03

1.70E-03

Heart wall

6.75E-02

2.14E-02

1.35E-01

3.64E-03

4.98E-03

Kidneys

3.92E-01

3.48E-01

1.29E00

4.27E-02

3.99E-02

Liver

1.01E-01

5.06E-02

2.77E-01

6.10E-03

4.74E-03

Lungs

4.78E-02

1.99E-02

1.10E-01

3.00E-03

3.36E-03

Pancreas

6.14E-02

1.97E-02

1.46E-01

2.37E-03

1.22E-03

Prostate

4.15E-02

1.23E-02

9.27E-02

1.55E-03

1.22E-03

Salivary Glands

6.42E-02

4.67E-02

1.74E-01

6.57E-03

8.32E-03

Red Marrow

4.11E-02

1.15E-02

9.39E-02

1.41E-03

1.03E-03

Osteogenic cells

6.00E-02

8.61E-02

1.75E-01

1.78E-02

1.04E-02

Spleen

7.72E-02

3.27E-02

2.12E-01

3.53E-03

1.75E-03

Testes

2.92E-02

8.58E-03

6.09E-02

1.20E-03

1.21E-03

Thymus

4.31E-02

1.22E-02

8.86E-02

1.75E-03

1.24E-03

Thyroid

3.55E-02

1.10E-02

7.60E-02

1.54E-03

1.22E-03

Urinary bladder wall

3.82E-02

1.12E-02

8.24E-02

1.48E-03

1.22E-03

Total body

3.57E-02

1.36E-02

8.13E-02

1.91E-03

1.74E-03

Effective dose

4.44E-02

1.86E-02

1.09E-01

2.47E-03

2.06E-03